BBIO•benzinga•
HC Wainwright & Co. Maintains Buy on BridgeBio Pharma, Lowers Price Target to $43
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2024 by benzinga